Med Tech Funding Mandate 24/25 Technology Update
NHS England are hosting a webinar on 31 January, 12noon – 1pm which will provide trusts with an update on the MTFM guidance for 24/25 and an overview of MTG76 for Apos Health.
The Med Tech Funding Mandate Policy is an NHS Long Term Plan commitment to get selected NICE-approved cost-saving devices, diagnostics, and digital products to NHS patients more quickly. 2021/22 marked the first year of the MedTech Funding Mandate Policy. To be supported by the MTFM, technologies must meet the policy’s three criteria and align with broader NHS England programmes (for example, Net Zero).
These criteria require that technologies:
- Are effective: Demonstrated through positive NICE Medical Technology Guidance (MTG) or Diagnostic Guidance (DG)
- Are cost-saving within three years: NICE modelling demonstrates a net saving within 3 years of implementing the technology, demonstrated by a published NICE resource impact template.
- Are affordable to the NHS: The budget impact should not exceed £20 million nationally, in any of the first three years.
NHS England together with the Academic Health Science Network and NHS Supply Chain continuously assess published NICE guidance to understand which technologies meet this criteria.
This webinar will be recorded and will be available on the MTFM FuturesNHS page.